R. Scott Huennekens
CIK: 0001365493
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 25, 2026QDEL
QuidelOrtho Corp
Award(A)DirectRestricted Stock Units (Equity Grant)
15.5K shares- - Jun 5, 2026NPCE
NeuroPace Inc
Award(A)Direct2.9K shares- - May 29, 2026QDEL
QuidelOrtho Corp
Exercise(M)DirectRestricted Stock Units (Equity Grant)
6.8K shares- - May 29, 2026QDEL
QuidelOrtho Corp
Award(A)Direct6.8K shares- - May 19, 2026NVST
Envista Holdings Corp
Award(A)Direct12.6K shares- - Jun 10, 2025NVST
Envista Holdings Corp
Award(A)Direct14.4K shares- - Jun 6, 2025NPCE
NeuroPace Inc
Award(A)DirectStock Option (right to buy)
8.7K shares- - May 29, 2025QDEL
QuidelOrtho Corp
Award(A)DirectRestricted Stock Units (Equity Grant)
6.8K shares- - May 22, 2025QDEL
QuidelOrtho Corp
Exercise(M)DirectRestricted Stock Units (Equity Grant)
2.5K shares- - May 22, 2025QDEL
QuidelOrtho Corp
Award(A)Direct2.5K shares- - Jan 6, 2025NPCE
NeuroPace Inc
Award(A)DirectStock Option (Right to Buy)
15.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  QDEL QuidelOrtho Corp | Award(A) Restricted Stock Units (Equity Grant) | 15,532 | - | - | Direct |
| Jun 5, 2026 |  NPCE NeuroPace Inc | Award(A) | 2,890 | - | $0 | Direct |
| May 29, 2026 | QDEL QuidelOrtho Corp | Exercise(M) Restricted Stock Units (Equity Grant) | 6,829 | - | - | Direct |
| May 29, 2026 | QDEL QuidelOrtho Corp | Award(A) | 6,829 | - | $0 | Direct |
| May 19, 2026 |  NVST Envista Holdings Corp | Award(A) | 12,585 | - | $0 | Direct |
| Jun 10, 2025 | NVST Envista Holdings Corp | Award(A) | 14,370 | - | - | Direct |
| Jun 6, 2025 | NPCE NeuroPace Inc | Award(A) Stock Option (right to buy) | 8,745 | - | - | Direct |
| May 29, 2025 | QDEL QuidelOrtho Corp | Award(A) Restricted Stock Units (Equity Grant) | 6,829 | - | - | Direct |
| May 22, 2025 | QDEL QuidelOrtho Corp | Exercise(M) Restricted Stock Units (Equity Grant) | 2,523 | - | - | Direct |
| May 22, 2025 | QDEL QuidelOrtho Corp | Award(A) | 2,523 | - | - | Direct |
| Jan 6, 2025 | NPCE NeuroPace Inc | Award(A) Stock Option (Right to Buy) | 15,507 | - | - | Direct |
1-11 of 11 transactions
About Huennekens R Scott
Huennekens R Scott (SEC CIK 0001365493) files insider reports with the SEC as Director of QuidelOrtho Corp (QDEL), Director of NeuroPace Inc (NPCE) and Director of Envista Holdings Corp (NVST).
Signal8 holds 11 ownership filings by Huennekens R Scott (2 Form 3, 9 Form 4), filed between Dec 10, 2024 and Jun 29, 2026. Those filings report 11 transactions, from Jan 6, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Huennekens R Scott's filings is in SAN DIEGO, CA.
Recent filings by Huennekens R Scott
- Jun 25, 2026: Grant or award of QDEL derivative securities (Form 4, code A).
- Jun 5, 2026: Grant or award of NPCE shares (Form 4, code A).
- May 29, 2026: Option exercise of QDEL derivative securities (Form 4, code M).
- May 29, 2026: Grant or award of QDEL shares (Form 4, code A).
- May 19, 2026: Grant or award of NVST shares (Form 4, code A).
Other insiders filing for QuidelOrtho Corp (QDEL)
- Siegrist Jonathan Philip, EVP of R&D & CTO
- Bowman Ronald Lee, Chief Human Resources Officer
- Hanson Bryan Michael, EVP Global Port. Mgmt & Mkting
- Young Micah W, Chief Financial Officer
- WIDDER KENNETH J, Director
- Chiminski John R, Director